Pharmaceutical Technology's In the Lab eNewsletter 04-07-2021

Pharmaceutical laboratories must work to maintain lab data integrity practices as the pandemic surges on and cybersecurity risks increase.

Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.

Rokote Laboratories Finland, an academic spin-out located in Finland, is working to develop a nasal spray vaccine against COVID-19 based on research from the University of Helsinki and the University of Eastern Finland.

The company plans to add 20,000 ft.2 to the site, tripling its clinical trial kit building capacity and further meeting the demand for cell and gene therapies, immuno-oncology, and other advanced therapeutics services.

The acquisition will expand the antimicrobial and antiviral testing capabilities of Sotera’s Nelson Labs business in the US.

The companies plan to enhance the platform’s capabilities in the biologics drug discovery space through their partnership.

Mikael Hagstroem has been named as the company’s new CEO.

The funding will accelerate the development of Antiverse’s AI-powered antibody drug discovery technology, which aims to speed up drug development from years to weeks.

The acquisition will add "off the shelf" PK profiling capabilities to Genesis Drug Discovery and Development’s portfolio.

Cobas pure integrated solutions is a new compact analyzer that combines three technologies in a single platform to simplify daily operations at labs with limited space and resources.

Piezo Motion has introduced a new micro-dosing pump that can replace separate lab devices traditionally used for fluid handling applications.